REBECCA PAFFENROTH: Open Payments
NPI 1720543218 · PEACHTREE CITY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,712 in 50 payments from 15 companies in 2025. Trend: 2023 $1,980 · 2024 $1,112 · 2025 $1,712
Food & beverage: $1,713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $360 |
| Lilly USA, LLC | 3 | $245 |
| Janssen Biotech, Inc. | 4 | $189 |
| Arcutis Biotherapeutics, Inc. | 5 | $169 |
| Amgen Inc. | 5 | $154 |
| Organon LLC | 1 | $125 |
| GENZYME CORPORATION | 4 | $108 |
| Organogenesis Inc. | 2 | $77 |
| Incyte Corporation | 4 | $68 |
| LEO Pharma Inc. | 2 | $65 |
Products named: RINVOQ, EBGLYSS, TREMFYA, Zoryve, OTEZLA, DUPIXENT, VTAMA, SKYRIZI.
Industry payments across GA — which companies pay providers there.
